Newborns From Patients Treated With ART (Assisted Reproductive Technology)

Prospective Cohort Study for Newborns From Patients Treated With ART in Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03993158

Enrollment

10000

Registered

2019-06-20

Start date

2010-01-01

Completion date

2050-12-31

Last updated

2026-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Related

Brief summary

The Prospective Cohort Study for Newborns from patients treated with ART was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.

Detailed description

Since the last twenty years, thousands of babies were born from infertile couples treated in our center. However, the short, and especially the long term prognosis of these children were barely known. Since last decade, Clinical Reproductive Medicine Management System/Electronic Medical Record Cohort Database (CCRM/EMRCD) has been used in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory for Reproduction and Genetics. Information of patients (POI, PCOS, Endometriosis, azoospermia, ect) were recorded comprehensively. In addition, information of each newborn from our center has also been kept in CCRM/EMRCD. The current project plans to recruit these newborn babies in our center. Biological samples, questionnaires and short/long term health data will be collected. The study is aimed to provide evidence for Newborns from patients treated with ART prognosis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Weeks to 40 Years

Healthy volunteers

Inclusion criteria

* All newborns from patients treated with ART in our center.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Birth weight	At delivery	Weight of newborns recorded in Kilogram
Number of newborns with Congenital malformations	At delivery	Any newborns with Congenital malformations will be recorded

Secondary

Measure	Time frame	Description
Height development of newborns	at age of 1 month, 3 months, 6months, 1 year, 3 years and 6 years	Record the height changes (in centimeters)

Countries

China

Contacts

CONTACTZhiqin Bu, M.D.

rmczzu@126.com037167967161

Outcome results